FDA
approval
· 2014-09-18
FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
Summary
The FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron), a formulation used to prevent chemotherapy-induced nausea and v…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SANCUSO (GRANISETRON)